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PROBLEM: 
The impact of bone loss due to different mechanical loadings In mlcrogravity is a major concern for 
astronauts upon reintroduction to gravitational forces In exploration missions to the Moon and Mars. 
it has been shown that astronauts not only lose bone at differing rates, with levels up to 2% per month, 
but each astronaut will respond to bone loss treatments differently. 
CURRENT METhODS: 
Pre- and post-flight imaging techniques and frozen urine samples for post-flight laboratory 
Immunoassays 
PURPOSE: 
To develop a novel, non-Invasive, highly . sensltive, portable, Intuitive, and low-powered device to 
measure bone resorption levels In 'real time' to provide rapid and Individualized feedback to maximize 
the efficacy of bone loss countermeasures 
SOLU11ON 
1. Collect urine specimine and analyze the level of bone resorption marker, DPD (deoxypridinoline) 
excreted. 
2. Antibodies specific to DPD conjugated with nanoshells and mixed with specimen, the change In 
absorbancefrom agglutination Is measured by an optical device. 
3. The concentration of DPD Is displayed and recorded on a PDA.
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Executive Summary 
Data from orbital missions by NASA have revealed dramatically accelerated bone 
density loss for astronauts living in microgravity. The NASA bioastronautics roadmap, which 
encompasses research, operations, and policies related to the risks associated with human 
space flight have identified that the risk of bone loss is a high priority. The risk rating for 
accelerated bone density loss for current ISS missions is rated at 2, for future lunar missions it 
is rated at 3 and for Mars missions rated at 3. Current countermeasures to mitigate bone loss 
includes nutrition, exercise (resistive and aerobic) as well as crew screening and preparation. 
However, there is yet to be a method of quantifying bone loss in real-time. Astronauts lose 
bone at differing rates and respond to treatments differently, so immediate evaluation of bone 
loss significantly aids bone density treatment and evaluation by providing rapid, individualized 
feed back. 
Team Taurus proposes a countermeasure effectiveness monitoring system which 
encompasses all forms of current and projected mitigation techniques that NASA employs to 
prevent bone losses for future missions. Team Taurus has undertaken the building of a novel 
device for use in space to quantify the real-time loss of bone mineral density. The device is 
designed to incorporate with NASA's existing waste management system for ease of collection 
of urine samples, and includes a nanoshell assay that is quickly read using a handheld 
spectrophotometer. 
The test uses a nanoshell conjugation assay followed by spectrophotometric 
quantification. Urinalysis was chosen for its convenience of use, small size, and accurate 
results. The device consists of three components: a collective compartment attached to the 
space toilet, a nanoshell assay for detecting deoxypyridinoline, and a near-IR 
spectrophotometer to measure the absorbance spectrum from the assay. 
The individual components of this device have been specially designed considering the 
constraints of microgravity, and the needs for accuracy and sustainability as dictated by 
astronauts in long duration space missions. The overall design of the system encompasses 
three distinct arenas: 
1. Sample collection device, incorporated with the space toilet 
2. Gold nanoshell-based assay specific to bone resorption markers 
3. A hand-held spectrophotometer and data collection system integrated with a PDA 
This document outlines the system engineering procedures as well as the significant 
steps involved in the design, testing and validation of the individual device components of this 
system. 
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II. Introduction of Project 
One of the major concerns of long-term space travel is the significant decrease in bone 
mineral density resulting from the microgravity environment. The weightless conditions unload 
much of the skeletal stress, leading to significantly decreasing levels of bone mineral density 
(BMD) recorded in specific load-bearing bones. Similar to the effects of osteoporosis, 
microgravity-induced BMD loss increases the risk of bone fracture, with the deleterious effects 
being magnified as the duration of the mission increases. 
NASA's current treatment methods, including supplements and exercise regimens, offer 
some mitigation of the effects of microgravity but are insufficient for space travel exceeding 
one year. Thus the rate of bone loss in microgravity presents a significant technical hurdle to 
long duration missions such as the manned mission to Mars. Although NASA is currently 
exploring a plethora of ideas to eliminate bone loss in astronauts, NASA has no method to 
quantify the efficacy of current and experimental treatments in real-time. Instead, NASA 
measures the bone loss before and after missions. This method neglects the time dynamics of 
bone loss and fails to provide ground control with real-time feedback of the results of bone loss 
treatment. 
The proposed solution is a portable and non-invasive device for measuring systemic 
BMD loss as indicated by levels of deoxypyridinoline (DPD), a bone-specific resorption marker 
found in urine. Many commercially available urine assays utilize DPD to measure bone loss 
because of both its specificity to bone and its resistance to interference from outside factors. 
The concentration of DPD in urine will be quantified using a novel gold nanoshell-based 
immunoassay. This method has been previously used to quantify solute concentration by 
measuring the decrease in absorption at a wavelength specific to the gold nanoshells. Gold 
nanoshells have unique optical properties that lead to a measurable decrease in absorption 
when nanoshells agglutinate around a target solute. Therefore, the use of gold nanoshells with 
conjugated anti-DPD will provide a characteristic emission spectra based on the agglutination 
of the sample. Thus by utilizing a portable spectrophotometer, precise concentrations of the 
bone resorption marker can easily be assessed in a rapid manner. 
Real-time feedback on the successes of attempted BMD loss treatments will allow 
NASA to understand the dose-response of these treatments. After analysis of the results, 
physicians can modify the treatment as necessary to tailor astronaut-specific regimens to 
minimize bone loss. The proposed device will measure systemic BMD loss in real-time to 
provide valuable data towards minimizing the deleterious effects of microgravity on bone 
density. In the following paper, one can view the technical specifications of this device as well 
as the design process used in its development. 
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III. Systems Engineering Process 
111.1 Process Planning 
As summarized by the NASA Bioastronautic roadmap (see figure 1), there are five main 
categories of health related issues that could be encountered by astronauts in microgravity. 
These are then further divided into 16 disciplines for researchers and scientists to answer. 
Team Taurus' bone remodeling monitor system falls into the bone loss discipline where 
accelerated bone loss and fracture risks are identified as a Level 2 priority risk for ISS, Lunar 
and Mars missions. Current countermeasures include nutritional supplementation, exercise 
(resistive and aerobic), and crew screening and preparation. Projected countermeasures for 
this risk includes: biophysical modalities, crew screening, exercise and fitness regimes, 
hormone replacement therapy, nutrition, pharmacological (biphosphates), rehabilitation 
strategies, spacesuit design and artificial gravity. 
Team Taurus has envisioned a system to track and monitor bone loss in real time to 
potentially minimize the effects of microgravity on the skeletal system through more informed 
management. The team has designed a four cycle project plan for the technical aspect of the 
system (see figure 2). Currently, in cycle three, the team is testing and refining a prototype for 
the system. At each level, the decision was made using Pugh analyses to provide a 
quantifiable method of decision making based on weighed importance of design criteria (see 
appendix E). The configuration control details the design stages of each component of the 
system. The next step of this project is to implement a new procedural operation on NASA 
missions to govern the utilization of the bone remodeling monitor. 
The overall process flowchart is depicted in figure 2. The top level for the process is a 
broken down into the four stages of development. Each cycle is expanded with further detail on 
the right. Initially the problem is clearly defined and the need for a new system is justified. A 
general literature search and review are conducted to identify past and present solutions 
utilized in space missions as well as on earth. These methods are then evaluated for 
performance, cost and feasibility using Pugh analysis to further develop the highest rated 
methods. Subsequently, a refined literature search is conducted to launch the project 
development into the second cycle- the development of the solution. Design criteria are 
explicitly determined based on environmental and operational constraints. The project team 
will seek expert consultation to refine the project development. The proposed solution will be 
partitioned into multiple components that can be developed and optimized separately to 
maximize efficiency (see appendix D for flowcharts of detailed component operations). As each 
component is modified it will be tested against the measurable design criteria until all criteria 
are satisfied. When each component is fully optimized, the system will be assembled and be 
further tested as a complete system. System analysis, including detailed cost, failure, safety, 
hazard and performance, will be conducted before the project design is complete. 
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Figure 1. NASA Bioastronautics Roadmap shows the administrative division of this system 
under the Human Health and Countermeasures discipline. 
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Figure 2. Design flowchart for the development of the bone density loss system.
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111.2 Design Criteria 
To most accurately monitor bone loss, measurements must be taken for each astronaut 
multiple times during a week. During normal use, an astronaut will attach his collection funnel 
to the space toilet and rotate the collection device to expose the honeycomb capillaries to the 
suction pressure. This allows a small stream of urine to be diverted into the pore spaces, which 
is then extracted with a syringe. The astronaut then transfers the sample to a cuvette where 
the urine containing bone markers combines with nanoshells coated with antibodies against 
the bone marker. Next, the cuvette is capped and placed into the sample holder of the 
spectrophotometer, which reads the attenuation in spectral properties of the sample. The 
astronaut has the option to manually record the level of his bone loss, or collect the data on an 
integrated PDA, which stores each astronaut's history and allows the data to be transmitted 
back to physicians on earth. Based on the rate loss data, experts will then tailor exercise 
regimes and dietary supplements to minimize the rate of bone mineral density loss of each 
individual astronaut. 
The following design criteria were chosen based on the restrictions implicit with space 
travel. The primary motivators for these criteria were crew operation, device complexity, and 
durability. For each criterion, a desired value and method of testing the prototype is specified 
by which the success of the design will be judged. 
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Design Criteria Testing Method 
Mass under 20 kilograms Scale 
Volume under 30 cm 3 CAD volume analysis 
training time under one day lime training of a user with no previous 
______________________________________ ?xperience 
Operating time under five minutes 1 lime designers' test runs 
ble to be dismantled and reassembled in lest assembly with tools available from 
space NASA on a KC-135 zero-g simulator flight 
r consult astronaut with work experience 
______________________________________ in microgravity to report on feasibility 
One device services all astronauts 2 lest device five times on two subjects 
Device digitally tracks all results 3 Successful if able to link device to data 
______________________________________ storage system 
Device gives repeatable results Five consecutive tests over one day vary 
______________________________________ by less than 10% 
Device gives accurate results lests have r2
 greater than 0.95 compared 
___________________________________ o DXA measurements 
Device withstands five years of use4 Extrapolate using accelerated wear & tear 
______________________________________ est 
Nithstands zero-g and high-g situations Device does not break in centrifuge or 
____________________________________ KC-1 35 zero-g simulator flight 
Nithstands pressure standard inside a Device operates at sea level atmospheric 
space vessel pressure 
Runs on ship's power supply or Device uses 28 or 120-160 volt DC, as 
rechargeable battery specified by NASA. 
Material should not be volatile Materials are on NASA-approved list 
Non-invasive procedure 5 Device works with sweat, urine, or saliva
1 
'Operating time under five minutes" signifies that the time the user interacts with the device to obtain 
a single measurement should be less than five minutes—this does not include analysis time, only the 
direct attention time required of the user. 
2 
"One device services all astronauts" implies all astronauts on the mission can measure their bone 
density with the same device. 
"Device digitally tracks all results" signifies that the device has integrated software and enough 
storage to track four measurements a week per astronaut for a five-year duration. Device will be 
RAIDed and backed up for data loss protection. 
"Device withstands five years of use" entails a durability tested by simulating the number of tests the 
device would experience during one space mission. The wear and tear associated with additional 
space missions may be extrapolated as necessary. Additionally, an accelerated time test will ensure 
that the internal mechanics of the device remain stable following the vibration of launch and could 
include lab vibration and sustained g-force testing. 
"Non-invasive procedure" denotes that the device will analyze a physiological sample obtained in a 
non-invasive way and testing will not be harmful to the astronauts' health in any way. Non-invasive 
testing includes the possibilities of QUS (qualitative ultrasound) or D)(A (dual energy X-ray 
absorptiometry) density scans, urine testing or sweat testing, but excludes collecting any blood 
samples. 
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111.3 Project Requirements 
Team Taurus is tasked with the development of a device that measures bone loss over 
the course of long duration missions. The team's budget for the year is $2075.00 and the goal 
is to develop a functioning prototype. The prototype will operate in the laboratory and fulfill the 
design criteria outlined in the previous section. Ideally, the prototype will be the first step in the 
development of a device that will accompany astronauts during sustained space missions. The 
data provided by the device will increase the efficacy of current and future treatments of bone 
loss in microgravity. Project requirements were assigned to each component of the device 
based on the constraints of microgravity and user operational requirements. 
Physical Requirements 
Device Portability: The device must be lightweight and portable. Its mass must be less 
than 20 Kg and its total volume has to be less than cm 3. To test these design criteria, a 
scale will first be used to measure the final weight of the prototype. A CAD model of the 
device will then be used to calculate the total volume. 
Non-Invasive: The device will utilize urine as the fluid for analysis. 
Usability 
Short User Training Time: The time required to train a person unfamiliar with the device 
to adequately operate the device must be less than one day. This criterion will be 
verified using test-training sessions. 
Short Operation Time: The time it takes the user to collect a urine sample and operate 
the LabView program on the PDA should be less than five minutes. This does not 
include analysis time, only the direct attention time required of the user. This will be 
tested with users trained to use the device before operation during the mission. 
Robustness: The PDA must have a backlight and be easily rebootable in the event of a 
program error. 
Device Characteristics 
• Device Reassembly: Astronauts must be able to disassemble and reassemble the 
device in space using the available tools. The plan is to test assembly with tools 
available from NASA on a KC-135 zero-g simulator flight (if possible) or consult 
astronaut with work experience in microgravity to report on feasibility. 
• Device Repeatability: To yield accurate bone density measurements, the device must be 
repeatable. This criterion will be assessed by using five consecutive measurements of 
one sample over one day and verifying that the measurements do not vary by more 
than 10%. 
• Device Accuracy: To verify the accuracy of the device, the linear relationship derived 
from the gold nanoshell based immunoassay must have an r 2 greater than 0.95 
compared to laboratory spectrophotometer measurements of the same samples. 
• Data Analysis and Storage: The PDA must have integrated software for data analysis 
and enough storage to track four measurements a week per astronaut for a five-year 
duration. The PDA must be able to upload data to the onboard computers using a 
Bluetooth uplink. 
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• Materials: All the materials used in the components of the device must be listed on the 
NASA-approved materials list, which will be verified during development. 
• Life Cycle: The device must be able to withstand five years of use. This criterion will be 
tested by extrapolating data from accelerated wear & tear tests. 
• Battety Life: The PDA must be able to power the device for at least 2 hours without 
charging. This will be evaluated by timing the maximum time the PDA can power the 
device. 
Urine Collection 
• Space Toilet Integration: The urine collection device must integrate into the space toilet 
and utilize the pressure found in this system to collect a urine sample. 
• Safety: The device must safely collect a urine sample without subjecting astronauts to 
the discomfort of urine exposure. 
• Urine Transfer: The user must be able to transfer urine from the collection device to the 
analysis device. 
Environment 
• Function in Microgravity: The device must function in microgravity. If possible, this 
criterion will be tested on the KC-135 zero-g simulator or otherwise assessed 
analytically. 
• Vibration: The device must withstand the vibration and forces of the vehicles entrance 
into earth's orbit. This criterion will be tested using a centrifuge to apply calculated 
forces to the device. 
• Power Supply Integration: The PDA must be able to recharge using the ship's power 
supply. The device will be designed to use 28 or 120-160 volt DC, the current power 
supply found on the shuttle. 
111.4 System design 
Collection device 
The urine collection receptacle is designed to temporarily store and collect urine sample 
from astronauts in microgravity. This feature is required, as fluid behaves differently in 
microgravity; the biggest problem is that fluid will not stay inside an open-top container unless 
pressure is applied to keep the fluid contained. Current waste urine collection is performed 
using a suction based space toilet— either the NASA Waste Collection System (WCS) or the 
Russian ACY, whereby a hose with airflow is provided. This collection device will be inserted at 
the beginning of the hose to take urine samples from the incoming stream. 
The device will divert a fraction of the incoming fluid stream to be temporarily stored 
(Fig. 3) until micturition is completed. The urine is able to be temporarily stored in the collection 
chamber due to the capillary action of the aluminum honey comb insert, which is a bundle of 
interconnected capillaries, providing a large amount of surface area for capillary action. 
Capillary action occurs when the relative attraction between the liquid and a solid is stronger 
than the cohesive intermolecular forces inside the liquid. In microgravity, this phenomenon is 
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more significant as the lack of gravity can draw the liquid to a much greater length, as 
gravitational forces balance the effects of capillary forces on Earth. 
Saivpe CoIecb	 ce
iTc'us 
Figure 3. Cross section view of the urine sample collection receptacle integrated 
with the space toilet. Fluid flow and airflow are shown. 
A locking mechanism has been added to prevent the escape of liquid during collection 
(Figs. 4 and 5). The astronaut will then extract the sample using a syringe, where the pressure 
from within the syringe will pull the fluid out of the capillaries and the collection chamber (Fig. 
6). In addition, a capillary-clearing mechanism (Fig. 4) has been included in the design to 
simplify the operation of the urine collection receptacle. 
=	
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Figure 4. The urine sample collection receptacle utilizes the airflow from the space 
toilet to clear the remaining fluid in the capillaries. 
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Figure 5. Locking is achieved by the use 	 Figure 6. The urine sample is then 
of a locking pin and a tapered interface	 extracted through a port using a syringe. 
between the components. 
The sample collection device will be analyzed, before prototyping, by using a series of 
computational simulations to determine the mechanical properties and functionality to reduce 
cost. The final device is intended to be fabricated using NASA approved materials, such as 
titanium for the collection device. Due to this, and the difficulty inherent in testing the design of 
this device to function in microgravity, this device will not reach the advanced stage of testing 
given the resources available. However, performing finite element analysis (FEA) and 
computational fluid dynamics analysis on the CAD model of the device will yield sufficient data 
to evaluate whether the device has met the design criteria. 
Vibrations & structural analysis 
Since the device is intended for use onboard 	 AN 
the Orion Crew Exploration Vehicle (CEV), the 
device was designed to avoid structural failure 
during launch and landing, as the device may 
experience up to 3g's of force and 60Hz of 
vibration during these events. FEA will be 
performed using the COSMOSWorks Designer 
component of SolidWorks with the CAD assembly 
of the device with the material properties 
incorporated into the model (Fig. 7). Using this the 
buckling/vibration failure test tool, a series of 
mechanical tests can be performed to determine 
whether the device meets the design criteria. 
For this test, the CAD file of the device will 
be tested for vibrations at 5g, which is greater than 
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Figure 7. FEA structural analysis performed on a 
deice similar to the sample collection device. 
Source: http://www
 advme. com/channel.jpg
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the 3g of vibration that occurs during shuttle takeoff. If no failures are detected with the 
software, the device is expected to withstand the vibrational forces of takeoff. [Solidworks, 
2008] 
Fluid flow 
Testing will be have to be performed on the 
device to determine whether fluid will flow into the 
collection chamber because the cost of developing an 
ideal prototype is prohibitive. The flow through the inner
"I, pathways of device will be determined using 
computational fluid dynamics (CFD) analysis rather 
than physical testing. Analysis will be performed using 	 _______ 
CAD-integrated fluid flow software such as FIoEFD or 
SolidWorks Flow Simulation (Fig. 8). These tools allow 	 •	 - 
the exact fluid pathway through the device to be (.. 
determined, as well as identifying more advanced 
properties such as the velocity of the fluid at every point 
along the device profile. As shown in the example (Fig. Figure 8. CAD-integrated fluid analysis 
showing flow and velocity distribution in a 
6), the colored regions show the fluid pathway through valve similar to the collection device's. 
a similar device. A maximum entrance flow of 21 mU Source: wwwflowmerics.com/files/ 
casestudiesil 069/johnson_design_02.jpg 
second is assumed, and the fluid flow into the collection 
device is assessed at this rate. A calculated flow rate of 
0.1 mUsecond or anything higher utilizing the CFD will be considered a success. If the 
calculated value is less, the number of collection capillaries in the device will be increased 
[FI0EFD, 2008]. 
Nanoshell assay 
Gold nanoshells are nanometer-scaled shells of gold colloid coating surrounding a silica 
core. Gold is selected as the metallic coating for its inertness and resistance to corrosion 
[Hirsch]. By altering the ratio of the silica core to the gold shell coating, the Plasmon resonance 
-	 frequency of the nanoshell can be tuned to specific optical 
-	
absorption and scattering [Hirsch, 2006]. Nanoshells can be 
,/ /' \	 fabricated to cover the visible spectrum as well as the near infrared spectrum from approximately 500 — 1300 nm, where 
-	 -	 optical transmission through tissue and fluids is optimal (Fig 9) 
Q =''ccJ	 [Hirsch, 2008]. 
--s 
• Co. Ra
_______	 Figure 9. 
j
'l ....	 Top: Demonstration of optical resonance dependence on core radius/shell 
- '
	 thickness for a 60 nm core. 
Bottom: Optical resonance wavelength versus core radius-shell thickness 
: 1 / -	 -	 ratio [Oldenburg, 19981. 
,.	
. 
__-. 
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To utilize this technology for a DPD assay, conjugation of anti-DPD antibodies to 
nanoshells will provide the same specificity of the ELISA test, but will minimize the complicated 
procedural aspects. Specifically, a prepared solution of conjugated nanoshells can be 
introduced to the analyte solution, then incubated for a short period of time, and analyzed 
using a spectrophotometer with an excitation LED and absorption photodiode tailored to the 
nanoshells' Plasmon resonance frequency. The agglutination of the antibody-conjugated 
nanoshells in presence of the analyte has been shown to cause a decrease in the extinction 
spectrum, which is easily detected using a spectrophotometer (Fig. 10) [Hirsch, 2006]. This 
spectral decrease is linearly related to analyte concentration by Beer-Lambert's Law and can 
therefore be used to calculate the concentration of analyte in solution. 
Nanoshells were synthesized using the 
method of Hirsch et al. [Hirsch, 2006], involving 
ro 60i in cameter. These cores	 •1 
were then covered in a gold shell approximately 
7nm in thickness using a 1-3nm gold colloid 
solution. According to laboratory standards, the
	
' synthesized nanoshells were diluted to the point
	 07	 - 
where the measured maximum absorbance was
	
0 
1 6	 _L	 5O	 6c'	 7Cc 80) 930 .30 
r-r, 
Once the nanoshells are synthesized, 
anti-lgG antibodies are attached with the Figure 10. Decrease in extinction spectrum as a 
electrostatic interactions between the antibodies result of nanoshell agglutination [Hirsch, 2006]. 
and the gold coating. Anti-lgG antibodies were 
chosen because of their low cost and their ability to act as a proof of concept. The optimal 
antibody concentration was found by preparing a range of nanoshell solutions with different 
concentrations of antibody and measuring the absorbance spectra of these solutions. The 
concentration that yielded the highest peak absorbance was selected as the optimal antibody 
concentration. This optimal antibody concentration was 10 pL of a 0.02 mg/mI solution. 
Next, a PEG-SH coating was added to the outside of the nanoshells bound to 
antibodies. This coating both protects the nanoshells against salt solutions that can be harmful 
to nanoshells and helps hold the antibodies to the surface of the nanoshell. The optimal 
concentration of PEG-SH solution was found using the same procedure utilized to find the 
optimal concentration of antibody solution. The measured optimal PEG-SH concentration was 
24 pL of a 10 pM solution. The final result was an antibody conjugated nanoshell with a PEG-
SH coating (Fig. 11). 
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Figure 11. Representation of finalized gold nanoshell with silica core, 
gold coating, conjugated antibodies, and PEG-SH coating. 
The finalized gold nanoshells have a peak absorbance at 630nm, the color red in the 
visible spectrum. Therefore, the spectrophotometer will measure the absorbance at this 
wavelength and determine the concentration of the analyte by using the data from a previously 
measured calibration curve. 
Progress with the assay has included nanoshells fabrication and antibody and PEG 
optimization levels. First, gold nanoshells with a silica core were synthesized with a peak 
absorbance at 630 nm. The optimal PEG coating was determined to be 24 pL of 10 pM stock 
per 1 mL nanoshells at 1.6 Abs. Antibody optimization has been pursued using less-expensive 
Anti-lgG instead of anti-DPD for the bone marker. The optimal antibody concentration was 
optimized at 10-15 pL of 0.02 mg/mL anti-lgG stock per I mL 1.6 Abs nanoshells. 
For complete synthesis, the antibody is allowed to react with 1 mL of 1 .6 Abs, and 
incubated for 1 hour. Then PEG is added to fill in gaps between antibodies, effectively coating 
the entire surface of the nanoshell to prevent breakage in salt solutions such as urine. 
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S pectrophotometer 
Spectrophotometer development has proceeded 
to the first round of prototyping. The physical 
components of the spectrophotometer include the 
electronic circuitry with an LED and photodiode, 
handheld PDA for measurement storage and analysis, 
and the Lab View code for voltage-concentration relations 
established through calibration. After the samples are 
prepared they are placed into the cuvette holder, shown 
in black between the two circuit boards (Fig. 12). 
This circuit outputs a voltage value from -2 to 2 V, 
and is extremely sensitive to changes in concentration; 
the spectrophotometer is sensitive to changes in the 
thousandths of volts, ideally corresponding to 
concentration changes less than lIlOO of a percent. 
Initial tests have shown sensitivity to changes in 5% of 
the concentration, but no samples were prepared for 
more sensitive tests. 	 phI:\ 
The current program (Fig. 13) displays the
Figure 12. Spectrophotorneter setup. 
voltage output. Once a correlation between voltage, Cuvette in holder between LED and 
nanoshell concentration, and metabolite concentration in photodiode circuits. Cables and connector 
the sample is determined, more complicated analyses block with PDA as user interface. 
can be quickly added via the LabView programming interface. The 
PDA supplies power for the spectrophotometer, and the entire 
system can be self-contained once prototyping is complete. The 
device is sensitive to ambient light, so a cardboard box is placed
	
.	 i1 
on top of the spectrophotometer to eliminate light from outside 
sources. An aluminum box with a flap for opening and swapping 
out samples has been designed for this purpose. 
The LabView code (Fig. 14) uses standard mobile unit VI's, 
which are adapted from the full VI set. The program is a voltage 
reader, providing a graph of the voltage reading and options for 
changing the sampling rate of the reading, as well as the read-in 	 ---
channel. This provides a quantifiable view of the reading from each 
sample. The reading is then recorded, and more samples may be 
tested to analyze differing concentrations of nano-particles. 	 Figure 13. LabView User 
Interface displayed on PDA 
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Figure 14. LabView block diagram of the voltage reader code. Information is read in 
through a mobile DAQ-mx set; other Vis provide the controls and create the output graph. 
The PDA is then connected via Bluetooth to a laptop running Microsoft Windows, where 
the data are synchronized and saved. As NASA space operations include laptops and PDAs by 
standard, this will require no additional room on the shuttle or station, and it will allow the 
program to be modified in-flight should the need arise. 
111.5 Result Verification 
Nanoshell assay 
Verification of antibody-nanoshell conjugation 
Since the antibody-based nanoshell assay technique for measuring bone marker 
concentration is a fairly new technique, verification by a commercial spectphotometer will be 
performed. 
Images of the nanoshell solution will be taken using a scanning electron microscope. 
These images will be compared to previous images taken by the Drezek lab at Rice University 
to verify the presence of both the PEG coating and antibodies. If the amount of PEG coating or 
the number of conjugated antibodies appears too low, the concentration of PEG-SH solution 
and antibody solution will be increased accordingly. 
Verification and characterization of nanosheli function 
Rabbit lgG is to be dissolved into 100mM phosphate buffered saline (PBS) at 2.2, 1.1, 
0.22, 0.11, 0.022, and 0 pg/mI. The nanoshell solution will then be diluted to 1.83 X 1O 
particles/mL using Dl water 0.20 pL of the rabbit lgG solution will be aliquoted into 480 pL of 
the nanoshell solution. After 5, 10, 15, 20, 25, and 30 minutes the absorbance spectra of all of 
the samples will be measured. This experiment should yield a calibration curve where the 
absorbance decreases somewhat linearly relative to the concentration of lgG in the solution. 
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This data will provide information on data precision and show how the nanoshells should be 
modified accordingly. If there is no measurable change in the absorbance for the different 
experimental conditions, this will show that the nanoshells are not functioning properly. 
Functionality of conjugated antibody-nanoshells over time 
As this assay technique is intended for use in long-duration space flight, there are 
concerns over the long-term viability of the biochemical components. To combat this, a supply 
of pre-conjugated antibody-nanoshell pairs will be frozen and stored as aliquots to eliminate 
much of the crew time necessary for performing the test. Testing the feasibility of storing the 
conjugated antibody-nanoshell pairs will verify the functionality of this technique. A batch of 
conjugated antibody-nanoshells will be produced, separated into five experimental time groups 
(e.g. 0, 1, 2, 3, 4, 5 weeks) and then stored in at -20°C. Samples will then be taken out, mixed 
and measured using a spectrophotometer at the time points to see the effects of time on the 
conjugation properties of antibodies-nanoshell. The measured peak absorbance of the 
experimental aliquots will be compared to the peak absorbance of the experimental groups to 
verify no significant decrease in absorbance. A significant decrease in absorbance is indicative 
of a breakdown of nanoshell structure. If there is deviation from the original absorbance, the 
procedure in which the nanoshells are stored will be modified. Since fresh batches of 
antibodies-nanoshell are typically made in laboratory studies, there are no data on the 
functionality of these biochemical particles after long duration freezing. 
Test for nanoshell viability in salt solution 
Salt solutions are known to be detrimental to nanoshells. Because the gold nanoshell 
based immunoassay will be used to measure the concentration of DPD in urine, since urine is 
a salt containing fluid, there is a need to test the viability of the synthesized nanoshells in a salt 
solution environment. To test this variable, a nanoshell solution will be diluted in Dl water until 
the peak absorbance is 1.6. This solution will then be centrifuged for 15 minutes at 3000 rpm. 
Afterwards, the nanoshells will be suspended in lmL of IXPBS. The absorbance spectrum of 
this solution at 0, 15, and 30 minutes will be measured using a laboratory spectrophotometer. If 
there is little variation in the absorbance spectra, then the nanoshells are stable for a sufficient 
period of time in the salt solution. If, however, there is variability > 10% in the maximum 
absorbance in the spectra, the experiment will be repeated by synthesizing nanoshells with a 
greater concentration of PEG-SH. This greater concentration of PEG-SH will hopefully help to 
protect the nanoshells from the salt solution. 
When the experiment was conducted, no significant variation in the spectra over the 
course of 30 minutes was observed (Fig. 15). The results of this experiment therefore 
indicatedthat the nanoshells will be functional in a salt solution such as urine for at least 30 
minutes. 
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Figure 15. Nanoshell spectrum in a salt solution. The limited variability shows stability in a 
salt solution, e.g. urine. 
Spectrophotometer 
Functionality test 
A linear trend is expected between measured absorbance levels and sample 
concentrations when the device is tested. Additionally, the device should produce corrected 
values within 10% of a laboratory—grade spectrophotometer. To perform this test, a series of 
diluted nanoshell solutions will be made that is the same as previous experiments (see 
verification and characterization of nanoshell function). These specimens are then placed in a 
cuvette between the light source and photodiode. While measurements are performed, all 
environmental variables will be kept constant, including room lighting, position of device and 
distance of cuvette from light source. From the voltage values collected, the absorbance 
values can be calculated, plotted against the known specimen concentrations and then linearly 
fitted to obtain a plot similar to figure 16. 
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Figure 16. Sample plot of absorbance vs. concentration of diluted sample for determining 
the quality of Team Taurus optical device's functionality versus a commercial device. 
These measurements are compared to those of the laboratory grade spectrophotometer 
(Fig. 16). The R2 of the linear fit is then calculated for variability comparisons. The measured 
absorbance values must be ± 10% of the laboratory grade spectrophotometer. If the R 2 is 
greater than 0.95, or if Team Taurus' spectrophotometer produces absorbances that are 
greater than ± 10% of those measured by the laboratory spectrophotometer, the case will be 
re-designed to reduce the variation caused by sample and circuitry instability, as well as to 
reduce or eliminate outside light interference. 
Repeatability test 
An intrinsic issue with a constructed optical device used for measurement at a highly 
sensitive level is the concern with repeatability. Factors of the device such as reading time and 
signal noise will affect the repeatability of measurements of the same sample. Under the 
design criteria, the device must have a repeatability variation under 5% when the same 
sampled is measured multiple times. To confirm the repeatability of the device, a stable 
specimen will be measured five times within one minute of each measurement in the 
breadboard configuration. If absorption measurements exceed ± 5%, the focus for the 
spectrophotometer will be on a case re-design to stabilize the system. 
111.6 System Analysis 
WBS and Gantt Chart 
A work breakdown structure was created to maximize the efficiency of the design 
process. It can be found in appendix C. It separates the distinct components of the device and 
lists the required steps to achieve the design objects and requirements. There are seven levels 
assigned to the processes such that tasks across the components can be developed 
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simultaneously at each level. Tasks with dependencies are indicated in subsequent levels of 
development. The Gantt chart was derived from the WBS (see appendix F). This chart 
provides a projected timeline for the project development based on task deliverables for each 
component over time. A separate version of the Gantt chart based on resources and 
deliverables over time was also created (see appendix G). 
Pugh Matrices 
In order to quantifiably rank design options, Pugh matrices were created for each 
development decision (see appendix E). In these matrices, design criteria were assigned 
weights of relative importance to accurately reflect system requirements. The standardly used 
technology is assigned a rank of 3 for all criteria. Each other option is ranked on a scale of 1-5 
relative to the standard technology with 5 indicating a significant improvement and I indicating 
a drastic regression. Then, each technology is given a weighted ranking and judged with 
technologies are worth developing. Several cases were analyzed to incorporate the positive 
aspects of each design idea to further improve the rank. 
IV. Transitioning Critical Technologies 
Currently, measuring the loss in BMD over time for astronauts is performed by freezing 
collected samples in space and subsequently analyzing the samples upon return to Earth. This 
is done by measuring for a specific marker correlated with BMD loss in blood, sweat, or urine, 
and then comparing the change in the marker's levels over time [Leach, 1979]. With this 
methodology, the detailed time dynamics of bone loss in microgravity is unknown. Additionally, 
the extent of the bone loss for each astronaut is unknown until the post-flight physical. 
Therefore, the integration of this new system would provide valuable information useful for 
mitigating the detrimental effects of a microgravity environment as well as for scientists to 
better understand the bone remodeling process under these conditions. 
Four fundamentally different non-invasive approaches to measuring bone density loss in 
space were evaluated as possible implementable technologies—qualitative ultrasound (QUS), 
dual x-ray absorptiometry (D)(A), body fluid biochemical marker analysis assays, and sweat 
patch measurements. The technologies were evaluated for durability, portability, and non-
invasiveness as well as other assigned requirements using a Pugh matrix (appendix E). The 
urine analysis device was selected as the technology to integrate into the NASA space 
program. 
The process inputs involved in the implementation of the Bone Remodeling Monitor 
include the spectrophotometer, a collection device for each crew member and the developed 
assay kit. It will be accompanied by a user's technical manual. It is recommended that a 
personal collection device for each of the astronauts on board be included to minimize 
contamination of the receptacle units. However, only one spectrophotometer and PDA will be 
necessary for all personnel. Further studies must be done before the specifics in the 
procedural frequency is determined. It is approximated that each astronaut should take a 
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measurement of their DPD concentration twice a week at the same time of day, to minimize the 
potential variation in the bone marker excretion. The collection device will be integratabtle into 
the waste collection system currently utilized by NASA. Following micturition, the astronaut 
must extract a sample of the urine in a syringe and combine it with a set volume of conjugated 
nanoshells. The resulting sample will be used in the spectrophotometer to determine the 
current concentration of the bone marker. This information will automatically be sent to NASA 
nutritionists and experts using the currently established web-based intranet system such that 
changes in the excretion of the bone marker can be tracked. The NASA experts can then alter 
the exercise and supplement regime as necessary. This procedure will be detailed in a user's 
technical manual. The associated risks to the implementation of the device into the space 
program are discussed in section X of this document. 
V. Integration of Systems Engineering Efforts 
V.1 Process Schedule 
The overview of the four cycle design process is shown in figure 17. It involves an 
iterative process of research, design, testing, risk assessment and refinement to ensure that 
hazards and risks are mitigated in the final implementation of the system. Due to the non-
invasive nature of the system, it is estimated the system could be ready for integration after the 
completion of two fiscal years. 
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Figure 17. Overview of the process schedule. 
V.2 Team Organization 
The project is advised by Dr. Maria Oden, a member of the Bioengineering faculty at 
Rice University. Mentors from the NASA Johnson Space Center include Dr. Ruttley and Dr. 
Tomko. The team has also sought the advice of experts with specialized expertise in the fields 
of bone physiology in microgravity, electrical engineering, nanotechnology and fluid 
management. A list of the project collaborators is included in the appendix J. Figure 18 
summarizes the team organizational setup. The internal team overseeing the planning and 
design of the system consists of five group members with the following responsibilities: 
• Charlie Foucar, Team Leader 
ESMD Space Grant Systems Report	 26
TEAM TAURUS 
- Serve as the external liaison 
- Maintain communications with mentors and other outside contacts 
• Shannon Moore, Budgeting 
- Responsible for budgeting and purchasing 
- Manage and maintain project documentation 
• Evan Williams, System Supei'visor 
- Edit documents and maintain homogeneity among all Team Taurus documents 
(font, style, format, etc.) 
- Evaluate design process and progress. Provide feedback to the group when 
necessary. 
- Back-up documents 
• Bodin Hon, Digital Media and Electronic Presentation Specialist 
- Lead and supervise CAD modeling and Power Point presentation 
- Microsoft SharePoint administrator, a project organization and document 
management productivity tool 
- Manage Google account 
• Leslie Goldberg, Purchasing 
- Compile, write and submit weekly updates 
- Supervise deadlines 
- Maintain Gantt chart 
- Purchase materials 
Figure 18. Team organizational flow chart. 
Project	 NASA 
Advisor	 Mentors 
I	 Collaborators	 I
Project Management
Team 
Technical Specialization Areas 
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VI. Implementation Tasks 
The second, and final, stage of the bone remodeling monitor involves the 
implementation of the device. This will require further testing and system analysis to validate 
the accuracy of the method and its effectiveness in managing treatment strategies. The device 
will first be tested against the design criteria with the testing methods (both outlined in this 
document). The software required for the operation and data collection of the device will be 
programmed in LabView Mobile Module and loaded onto the FDA. A user manual will be 
generated that includes basic software troubleshooting methods as well as methods to replace 
hardware using tools on board the space shuttle. 
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VII. Cost Effectiveness Analysis 
A quantifiable cost-effective analysis is difficult when the health of astronauts is 
involved. The estimated cost of implementation is low (approximately $150,000 dollars per 
unit) compared to total mission budgets for manned space flight, which can range anywhere 
from $500 million to $170 billion (depending on the length and objective of the mission). Our 
device will ideally lead to fewer fractures and less irreparable damage to astronauts' skeletal 
systems. Although these effects would have a large impact on the probability of success for 
missions, it is difficult to assign a dollar value to these effects at this time. 
Cost Estimation and Budget Planning 
Funds for this project come from CBEN and TSGC goal and level-based project 
funding. A total amount of $1,000 in lump was received at the project's beginning. Funds from 
TSGC are awarded in the amount of $125 following completion of each cycle, with an 
additional $400 possible pending completion of three option areas. For semester 1, option 
areas were completed after cycle 2. Figure 19 illustrates the project's past spending profile as 
well as the projected income and expenditures through the project's completion after the 
second semester, indicated in orange. 
As depicted in the graph, all expenditures fall within the range of the allocated budget. 
There is sufficient funding to support our project at all stages. 
- Spending	 Balance 
1,600 
1,400 
1,200 
1,000 
C
800 ______________________ 
600
1 
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Figure 19. Cost engineering, budget for the system design. 
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VIII. Design Configuration Control 
Collection Device: Configuration 1.0 
Collection device design began in September 2008, with three prototypes considered 
for the system (Fig. 20). The first proposed collection method (middle) takes advantage of 
airflow from the tube and redirects a fraction of the urine stream into a cuvette. A valve can be 
used to adjust the flow and close the system after the cuvette is full. The second proposed 
collection (middle) method employs a syringe to collect urine from the pressurized tube. This 
technique would allow astronauts to collect a specific volume of urine and deposit the sample 
directly in our device. The third proposed method of collection (right) would employ a sponge in 
the collection funnel of the WMS. After the sponge became saturated, it could be moved to a 
compression device that would collect the urine in a pressurized receptacle and deposit it into 
our device. The cuvette could then be seated and carried to our device. Pugh matrices were 
created for the evaluation of each design (see appendix E), and as the system developed from 
theoretical implementation to practical construction, the system was refined. 
Figure 20. Initial ideas (September 2008) for the collection chamber of the urine sample collection device. 
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Collection Device: Configuration 2.0 
The previous configuration lacked an element to be able to hold fluid in a open-
container in microgravity. After further research, a similar device was found to successfully 
perform similar function. The Urine Receptacle Unit (URA) used for the Apollo mission was 
used to temporarily hold urine after astronauts micturate in an open-ended container before 
the urine is vented to space. This is achieved by using the surface tension properties of 
capillary bundles, in the form of perforated aluminum honeycomb (0.32cm pore size); 
additionally the honeycomb also acts as a static-phase air-liquid separator. Thus this 
configuration is focused on adding aluminum honeycomb into the device. 
Figure 21. collection device in configuration 2.0. 
Left: Exploded view Right: Isometric view 
Further development concept of urine collection device that utilizes capillary bundles to hold 
fluid in microgravity. Subsequent extraction of the urine sample is performed by a syringe. 
The sample will be temporarily stored inside the capillaries while flowing down the sides 
to collect in the collection chamber until after the entire space toilet system is shut down. 
Afterwards, a syringe will be inserted into a port to evacuate the sample in the chamber. 
An additional feature add in configuration 2.0 is an integral capillary clearing mechanism 
where rotating of the base exposes the capillaries to the airflow from within the system to 
empty the capillaries. 
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Figure 22. Integrated honeycomb-clearing mechanism the collection device. Rotating of the device 
toggles the collection device between a cleaning position and a collection position. The cleaning position 
exposes the capillaries and the temporary collection chamber to the pressure provided by the space 
toilet and removes urine from the capillaries. 
Figure 23. Cross section of urine sample collection device showing the pathways of urine and air. 
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Collection Device: Configuration 2.1 
Development was focused on the locking mechanism which resulted in the addition of 
0-rings grooves, a position locking pin and a tapered cam-lock mechanism. The tapered 
interface and the locking pin are added to counteract any vertical movements during the 900 
rotation. The pin is inserted after interfacing the 2 components; it also prevents over-rotation 
by following the rotation track (grey) so rotation is limited between COLLECT and EMPTY. 
aperea interlace 
Figure 24. Cross section of partially exploded collection device showing the locking mechanism. 
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Figure 25. Cross section of partially exploded collection device in LOCKED position showing the capillaries 
bundle and collection chamber. 
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Spectrophometer: Configuration 1.0 
Initial design on the method for quantifying the assay focused on what method to use: 
spectrophotometry, colorimetry, or a color-matching method similar to litmus paper. After these 
three designs were weighed against the design of the bone marker assay, spectrophotometry 
was chosen. For such a system, a fixed-wavelength LED tuned to the nanoshells, a 
photoreceptor, and a box preventing outside light yet allowing samples to be interchanged was 
required (Fig. 26). 
Photoreceptrr rirri ut 
with micror 
Rechargeable battery to 
power spectrophotometer 
Capped cuvette inserted into 
adapter to fix its position
LED 
Cuvette containing 
specimen 
Figure 26. Isometric views of spectrophotometer in configuration I with cuvette and adapter shown. 
The photodiode would detect the intensity of light after passing 
through the contents in the Cuvette; a voltage reading would be given out 
and this could then be converted into a concentration reading using 
algorithms performed by the microprocessor with a calibration 
routine performed before a sample reading using cuvettes 
containing samples with known concentrations. 
The initial design was based on the use of an 
independent microprocessor for data analyses. This required 
a power source, display and buttons for the user to 
interface with.
Capped Cuvette to 
prevent contamination 
and fluid escape 
Figure 27. After extraction of sample from the 
collection device, urine is injected into cuvettes and 
then capped to contain fluid in microgravity. 
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Spectrophotometer: Configuration 2.0 
Development for the spectrophotometer was refocused on the inner mechanisms and 
layout, resulting in a complete redesign of the device. The main difference is the addition of a 
rotating multi-cuvette holder (carousel) to allow automatic system calibration to reduce the 
interaction time required by the astronauts. Furthermore additional components are added 
which includes: a 15-pin D connector block, a LED circuit board & a photodiode circuit board. 
_..- Photodiode 
circuit & 900 
bracket 
I 
Figure 28. Two concepts of the inner mechanism of the spectrophotometer in configuration 2. Both 
includes the rotating carousel multi-cuvette holder with the left being a more condensed design. 
However, the addition of the carousel resulted in the addition of around 10 more 
components, making this system overly complicated and hard to fix and maintain; thus it was 
decided to eliminate the carousel to reduce the complicity as well as the cost. 
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Spectrophotometer: Configuration 3.0 
Decision was made to focus on simplicity and to developing the most cost efficient 
solution, thus the carousel plan was abandoned in favor of a single cuvette holder design. 
Given the final decision to utilize a PDA and NI Labview Mobile as the primary user's interface 
with the spectrophotometer; a detailed bill of materials could be compilated which would 
include a 15 pin D-sub female connection to connect the spectrophotometer with the PDA 
though a cable. In trade with this additional component, the microprocessor, power source and 
display screen can be eliminated from the spectrophotometer, in addition this would also 
reduce the risk of exposing critical electrical components to possibly wet cuvettes. 
p 
Figure 29. Front & Back Isometric view of the spectrophotometer. Left: The device is shown is its open 
position, which features a sliding mechanism. Right: The device is shown in its closed position with a 
cuvette placem?nt orientation' arrow painted in white. 
Sliding Mechanism 
The spectrophotometer features a sliding mechanism as a means of opening the door to allow 
access to the inner compartment. The sliding mechanism consists of a groove and a pin to 
lock its travel. 
Connection Port 
The device features a l5pin D-sub female connection oriented 25° upwards to allow the data 
cable to be linked to the top of the PDA. 
ESMD Space Grant Systems Report
	 36
Movemen 
pin & track
TEAM TAURUS 
Figure 30. Bottom isometric view of the 
spectrophotometer. The device is shown slightly opened 
so that the movement track and pin can be seen. 
Cuvette Holder 
A standard commercial cuvette holder is 
integrated with the device which includes the 
correct positioning for a standard I mL cuvette. 
Printed Circuit Boards 
PCB for the LED circuit and Photodiode circuit 
is and secured on both sides of the cuvette to 
for consistent spectral measurements. 
PB positioning 
Sample cuvette inserted into 
cuvette holder 
Figure 31. Isometric view of the 
spectrophotometer. The device is shown 
as Slightly opened to show the 
compartment where the sample cuvette 
would be inserted for analyses. 
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PDA Interface 
The user-interface of the device utilizes a PDA with National Instrument (NI) Labview 
Mobile DAQmx Base installed. PDA running the platform Pocket PC 2003, Mobile 5 or 6 are 
compatible as long as they have a Compact Flash (CF) slot; this is necessary as the NI DAQ 
(data acquisition) card comes in the form of a CF card. Connecting the device through the 
l5pin D-sub connection to the PDA by the means of a cable provides it with 3.3V, which is 
sufficient to power the LED and photodiode circuits in connected in parallel. The advantage of 
using the PDA instead of an independent microprocessor is that more complicated functions 
can be programmed to be displayed on the high-resolution screen. The touch screen also 
allows a more interactive solution to perform the acquisition. Furthermore, the PDA is already 
an integral instrument used onboard the ISS and NASA's other vehicle systems, thus the 
program could be easily installed into another PDA with the DAQ card to start data acquisition. 
However, the cost is much greater for this option as the NI CF-DAQ card CF-6004 and 
cable cost around $800USD, while a PDA costs around $200. A microprocessor and 
development board would cost only around $200. 
cu
Compatible PDA with CF card 
slot 
Figure 32. PDA interface with spectrophotometer. 
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IX. Tradeoff Assessment 
Pugh Matrices 
Throughout the design process critical decisions are made at each stage using Pugh 
analyses to make decision in concept exploration and development in areas such as feasilbilty, 
affordibility, alternative system configurations and component/part designs. 
Pugh matrices were created for each development decision (see appendix E). In these 
matrices, design criteria were assigned weights of relative importance to accurately reflect 
system requirements. The standardly used technology is assigned a rank of 3 for all criteria. 
Each other option is ranked on a scale of 1-5 relative to the standard technology with 5 
indicating a significant improvement and I indicating a drastic regression. Then, each 
technology is given a weighted ranking and judged with technologies are worth developing. 
Several cases were analyzed to incorporate the positive aspects of each design idea to further 
improve the rank. 
Monitoring Technique Selection: Assay-based 
The initial trade report is to decide whether a imaging-based or assay-based technique 
is the most feasible technique to analyze bone mass density loss in a real time manner. The 
critical tradeoff is deciding between the power-consumption and weight of the imaging-based 
technique such as a bulky DEXA (X-ray imaging device) and the biological characteristic of an 
assay-base technique. Since this system is intended for a long duration mission abroad the 
CEV; size, weight and power consumption are the most heavily weighted criteria. The assay-
based approach based on the criteria mentioned beforehand as well as it is not invasive. 
Sampled Fluid Selection: Urine 
Sweat, urine, blood, and saliva were considered as potential candidates for our device. The 
favorable and unfavorable criteria were evaluated for each of the different options in a Pugh 
matrix in order to narrow down the selection. Urine was selected for use in the final design due 
to its ease, and non-invasive method of collection as well as the presence of a multiple 
markers that can be used to track the bone remodeling process. 
Bone marker selection: deoxypyridinoline (D-Pyr) 
Bone remodeling markers present in urine were evaluated for use in the biochemical assay to 
determine bone loss. Bone resorption markers were chosen over bone formation markers due 
to their quick response time to intervention, using the Pugh matrix, the most stable, unique 
urinary bone marker was selected out of the list. 
Quantification Method: Spectrophotometry 
Quantification methods such as spectrophotometry and fluorescence spectroscopy relate 
electromagnetic intensity to wavelength. Specifically, a spectrophotometer can quantify 
scattered light intensity, absorption and fluorescence by measuring light from a source, while 
fluorescence spectrophotometry measures the intensity of fluorescence from a sample after 
excitation [Braun, 2008]. 
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X. Risk Analysis 
Following the device design, detailed risk assessment was done in order to minimize all 
risks associated with the system. These include risks that jeopardize the health of the 
astronauts, the success of the mission, and program costs. The technical risks associated with 
each component of the device were imagined and assigned an associated severity and 
consequence. Risk level was decided using a 5x5 risk assessment matrix and displayed in 
figure 32. The non-invasive interface minimizes immediate safety risks to the user. Therefore, 
there will be few, if any, health risks. However, secondary effects arising from the prescribed 
treatment modifications based on information received from the diagnostic tool pose minimal 
risk. Astronauts could inadvertently be harmed by any large errors in the device because of the 
decreased efficacy of bone loss treatments. For example, residual bone marker molecules left 
in an improperly cleaned system could lead NASA to prescribe too little or too much of a dose 
than is actually required. While brainstorming possible engineering failures, the design team 
concluded that most risks could be decreased to an acceptable level, so long as methods to 
ensure sample purity and device cleanliness were incorporated into the design. For further 
precision and accuracy before implementation, the device will be tested against other robust 
spectrophotometers which are standardized for laboratory use on Earth. Other risk factors, 
inherent to all devices with their own power sources, have been considered. These include 
voltages and currents that could, under the wrong conditions, light fires, produce smoke, or 
overheat. Risks of our device incurring these are negligible due to the low power requirements 
of this device.
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X. Conclusions 
Over the course of the next few months, Team Taurus plans to further test and improve 
the collection device, portable spectrophotometer, and nanoshell assay. Possible 
improvements, such as a calibration carousel that would allow a user to load multiple samples 
for automatic calibration curve have been considered. More importantly, Team Taurus has 
outlined a series of functional experiments that will allow evaluation and improvements on the 
accuracy and precision of the device until it is ready for field testing. 
Nanoshells have already been successfully synthesized for this device, with plans in 
action to further test the nanoshells to maximize their efficacy. Subsequently, the conjugated 
nanoshells are to be imaged using a scanning electron microscope to confirm both successful 
antibody conjugation and adequate PEG coating of the nanoshell. The decrease in absorption 
upon nanoshell agglomeration will be additionally verified by testing a solution of nanoshells on 
a laboratory-grade commercial spectrophotometer. 
Lastly, a finalized urine collection device will be built using aluminum that will integrate 
with the space toilet found in NASA vehicles. This device will utilize the capillary action in 
capillary meshes to the control fluids in microgravity. The successful integration of these three 
components is the end goal for the project. 
Currently there is an initial prototype of the bone remodeling monitor. Custom 
nanoshells have been synthesized, a functioning, preliminary portable spectrophotometer has 
been built, as has a plastic prototype for the collection device. During missions involving 
extended periods of space travel, NASA will be able to use a device like this device to monitor 
the efficacy of their proposed bone density loss treatments in real time. Using this data, 
mission control will be able to modify the treatment regiments to maximize their effectiveness. 
Team Taurus hopes that this device will help make long-term manned space travel more 
feasible in the future. 
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XI. Appendices 
A. List of Acronyms 
Ab Antibody 
BMD Bone Mineral Density 
CAD Computer Aided Design 
CBEN Center for Biological and Environmental Nanotechnology 
CEV Crew Exploration Vehicle 
CF Compact Flash 
CFD Computational Fluid Dynamics 
DAQ Data Acquisition 
DPD/D-pyr Deoxypyridinoline 
D)(A Dual X-ray Absorptiometry 
ELISA Enzyme-Linked Immunosorbant Assay 
ESMD Exploration System Mission Directorate 
FEA Finite Element Analysis 
FY Fiscal Year 
lgG Immunoglobulin G 
ISS International Space Station 
JSC Johnson Space Center 
LED Light Emitting Diode 
LCD Liquid Crystal Display 
NASA National Aeronautics and Space Administration 
NI National Instruments 
NS Nanoshell 
PBS Phosphate Buffered Saline 
PCB Printed Circuit Board 
PDA Personal Digital Assistant 
PEG Polyethylene Glycol 
PEG-Bis-A Polyethylene Glycol 
PEG-SH Polyethylene Glycol Thiol 
PERT Program Evaluation Review Technique 
TSGC Texas Space Grant Consortium 
QUS Qualitative Ultrasound 
RAID Redundant Array of Inexpensive Disks 
URU Urine Receptacle Unit 
VI Virtual Instrument 
WBS Work Breakdown Structure 
WCS Waste Containment System 
WMS Waste Management System
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B. Bioastronautics Roadmap Flow Chart 
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C. WBS 
Handheld device for measuring bone mineral density loss in space 
Fluid collection device 
Collection device design 
Integration with existing WMS 
Placement within system 
Design of locking mechanisms 
Function of device 
Selection of fluid collection method 
Selection of cleaning protocol 
Fluid extraction 
Collection device prototype 
3D rapid prototype 
CAD sketch-ups 
Dimension determination 
- Assay
Casted plastic prototype 
Material selection 
Manufacturer selection 
Selection of bone marker (D-pyr) 
Determination of bodily fluid 
Assay type selection (nanoshell immunoassay) 
Analyte concentration range determination 
NS concentration 
Ab/NS conjugation 
Gold NS synthesis 
PEG-SH optimization 
Ab concentration optimization 
PEG-Bis-A optimization 
PBS stability test 
Absorbance decrease experiment
Color Legend 
Level 1 
Level 2 
Level 
evel 
Level 5 
Level 6 
Level 7 
Analyte concentration test 
Validation with spectrophotometer 
- Detection Method/Spectrophotometer design
Spectrophotometer Design 
Casing
3D prototype 
Circuitry encasing 
Locking and sliding 
Component securement 
Testing, analysis and redesign 
Circuitry 
Component (LED and photodiode) selection 
Nanoshell peak absorbance wavelength 
Signal amplification and processing 
PDA Integration 
PDA selection 
Device Calibration 
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D. Flowcharts - Detailed Component Operations 
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PROJECT EXPENDITURES Wndor 
Bone Remodelinq '1onitcr 
Labview Software 
Misc Parts ror Repair 
Collection Device
National 
NI Cornector Cables Instruments 
Reusable Cuvettes and lids Starna Cells 
Nanoshells WI Conjugated Anti-Dpyr Nanopartz
S4.500.00 
S1.000.00 
$500.00 
191067-ORS	 S29.00 
51,000.00 
$150,000.00 
NDITURES S157.829.0( 
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G. Budget Plan 
Tesm Tth,rus 
Development Cost Protection 
OOfl crY CVDCIJflITI 0CC	 ,h,,n,Iw	 C.I4.4 rs 
GE rleafthcare	 NA934-IOOUL Rabbit IgG	 Lifescience S65.00 
Anti-rabbit loG
	
Siama-Aldrich	 R2004-IMG S59.00 
HEPES buffer	 Sigma-Aldrich	 H0887-2OML 515.90 
Anti-Rabbit I g G	 Sigma-Aldrich	 R5506 $106.00 
laG from rabbit serum	 Sigma-Aldrich	 18140 S19.50 
ProE Software, student edition 	 ptc.com	 Wildfire 4.0 $129.99 
National	 191067-ORS NI Connector Cables	 Instruments S29.00 
National	 779198-01 NI Connector Block	 Instruments S49.00 
Online Used
	
HP Ipag POA Pocket PC 
PDA	 Vendor	 Computer 2215 599.00 
LED, PC Board	 Radioshack S7.27 
Aluminum matenals for casino
	
Alcore $100.00 
cuvettes, lids	 Starna Cells 550.00 
3D prototypyinci	 Rice BIOE Dept. $355.00 
Rice Machine Shop Mechanical loccs 550.00 
Misc Laboratory Chemicals	 ice BLOE Dept. $150.00 
Nanoshells	 Nanopartz $400.00 
Arti-dpy r	 Sigma-Aldrich $500.00 ____________ 
EXPENDITURES $2,184.66 
'IARNINGS	 Amount _________ _________ 
TSGC Design Com petition Grant	 $1,275.00 
CSE N (Nanotechnolo qy Grant)	 $1,000.00
EARNINGS $2,275.00 
I	 Balance __________ $90.34 
The projected implementation costs figure estimates the cost of implementing one of 
our devices on a two year mission. Some of the costs, such as the costs of nanoshells, 
increase with the implementation of more units. However, other costs, like those for software, 
would only be paid once and would not increase with the implementation of more units. 
Team TaLrus 
m plementation Cost Protection
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I. Collaborators 
Dr. Tara Ruttley [JSC-EB] 
Biomedical Systems Division 
NASA Johnson Space Center 
2101 NASA Road I - Houston, TX 77058 
Email: tara.m.ruttley@nasa.gov ph: (281) 483-9615 
Dr. Ruttley is a member of the Biomedical Systems Division at NASA. Her previous work 
includes her role as Lead Hardware Engineer on the Health Maintenance System on the 
ISS. 
Dr. David Tomko - NASA Headquarters 
Advanced Capabilities Division - Human Research Program 
NASA Johnson Space Center 
2101 NASA Road 1 - Houston, TX 77058 
Email: dtomko@nasa.gov ph: (202) 358-2211 
Dr. Tomko is a member of NASA's Advanced Capabilities Division. 
Vengadesan Nammalvar - Rice University 
Department of Bioengineering 
Email: venkyn@rice.edu 
Phone: (713) 348-2638 
Vengadesan has been an invaluable resource for our nanoshell synthesis. He is a graduate 
student in Dr. Drezek's lab who is in charge of the lab's nanoshell research. He has already 
helped us to synthesize functioning nanoshells for our device. 
Dr. Rebeka Drezek - Rice University 
Department of Bioengineering 
Email: drezek@rice.edu 
Phone: (713) 348-3011 
Dr. Drezek has opened her lab for our use. We have used her equipment for nanoshell 
synthesis and plan to use her lab for testing our device. Her cooperation with our project 
has been critical to the building and testing of our device. 
Dr. Susan A. Bloomfield - Texas A&M University 
Department of Health & Kinesiology and Intercollegiate Faculty of Nutrition Director of the 
Bone Biology Laboratory 
Email: sbloom@tamu.edu 
Phone: (979) 862-1181 
Dr. Bloomfield will be an invaluable resource to the team. She specializes in bone biology 
under microgravity conditions. In addition to a tour of her research laboratory, she will be 
able to help determine the feasibility of the design. 
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Dr. Nancy Butte - Baylor College of Medicine 
USDA/Agricultural Research Service's Children's Nutrition Research Center 
Email: nbutte@bcm.tmc.edu
 
Dr. Butte will provide necessary insight pertaining to the urine assay component of the 
design. She has offered to give a tour of her laboratory as well as the laboratories of her 
colleagues so that the team can get a personal, in-depth understanding of the current 
detection methods used. 
Dr. Melissa Knothe-Tate - Case Western Reserve University 
Experimental and Computational Mechanobiology Laboratories 
Email: knothetate@case.edu
 
Phone: (216) 368-5884 
Dr. Knothe-Tate holds a joint appointment in the Biomedical and Mechanical Engineering 
departments at CWRU. She is specifically focused on bone biology and the 
mechanobiological influences on bone, and has performed research regarding bone 
strength in microgravity. She will be a valuable resource for helping us to determine 
which bone degradable products will be most feasible to test. 
Dr. Adrian D. LeBlanc - Baylor College of Medicine 
Departments of Medicine and Orthopedic Surgery 
Director of Division of Space Life Sciences 
Email: leblanc@dsls.usra.edu 
Phone: (713) 793-1131 
Dr. LeBlanc is interested in building systemic bone loss monitoring device for use in space 
flight. His efforts focus primarily on imaging techniques, but his expertise would serve as a 
valuable resource to the design project. 
Dr. James F. Young and Dr. Richard Baraniuk - Rice University 
Department of Electrical and Computer Engineering 
Email: young@ece.rice.edu
 and richb@rice.edu (respectively) 
Phone: (713) 348-4721 and (713) 348-5685 (respectively) 
Dr. Young and Dr. Baraniuk have extensive research interests in electrical engineering 
design that will be useful during the design process of the analysis component of the 
device. In particular, Dr. Baraniuk explores signal-processing algorithms that accommodate 
low power consumption for long-term battery operation. Dr. Young is an expert in the 
development of optical devices, which is useful for the development of the optical device. 
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